RxAnte Recognized by the Financial Times as One of the Americas’ Fastest-Growing Companies for the Second Consecutive Year

RxAnte is proud to announce that we have been recognized by the Financial Times as one of the Americas’ Fastest-Growing Companies for the second consecutive year. This year, we moved up in the rankings from No. 163 in 2025 to No. 93.

This recognition reflects the momentum RxAnte has built through continued innovation in pharmacy care management and healthcare analytics. As health plans and providers face growing pressure to improve outcomes, reduce costs, and better support members with complex medication needs, RxAnte has continued to grow by delivering targeted, data-driven solutions that help meet those challenges.

Compiled by the Financial Times in partnership with Statista, the annual ranking highlights companies across the Americas with the strongest revenue growth over a defined three-year period. The ranking is based on independently verified revenue performance, and eligible companies must meet specific revenue thresholds, remain independent, and demonstrate primarily organic growth.

At RxAnte, our mission remains the same: to improve medication use and strengthen healthcare outcomes through advanced analytics, pharmacy care management, and solutions that create measurable value for healthcare organizations and the people they serve. This recognition reinforces the impact of that work and the opportunity ahead.

We are grateful to our employees, clients, and partners for helping make this achievement possible. We also thank the Financial Times and Statista for this recognition.

To read more about the ranking, visit the Financial Times website.